z-logo
Premium
A double‐variant transthyretin allele (SER 6, ILE 33) in the Israeli patient “SKO” with familial amyloidotic polyneuropathy
Author(s) -
Jacobson Daniel R.,
Buxbaum Joel N.
Publication year - 1994
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.1380030313
Subject(s) - transthyretin , transversion , polyneuropathy , biology , genetics , transition (genetics) , exon , allele , mutation , amyloidosis , point mutation , compound heterozygosity , dna sequencing , genomic dna , dna , microbiology and biotechnology , gene , medicine , endocrinology
Transthyretin (TTR) isolated from amyloid fibrils from an Israeli patient (“SKO”) with familial amyloidotic polyneuropathy has been studied by two groups of investigators. Originally, a position 49 Thr→Gly substitution was reported; subsequently, a position 33 Phe→Ile substitution was found instead. We have studied DNA from this patient by single strand conformation polymorphism analysis, restriction analysis, and DNA sequencing. On one allele, exon 2 contained both a T→A transversion at the first position of codon 33, encoding the previously described Phe→Ile substitution, and a G→A transition at the first position of codon 6, encoding a Gly→Ser substitution. The originally reported position 49 mutation was not encoded in the genomic DNA. This is the first report of a TTR double‐variant allele in a patient with TTR amyloidosis. © 1994 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom